Meeting the challenges of NTM-PD from the perspective of the organism and the disease process: innovations in drug development and delivery
Abstract Non-tuberculous mycobacterial pulmonary disease (NTM-PD) poses a substantial patient, healthcare, and economic burden. Managing NTM-PD remains challenging, and factors contributing to this include morphological, species, and patient characteristics as well as the treatment itself. This narr...
Main Authors: | Roald van der Laan, Andy Snabilié, Marko Obradovic |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-12-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12931-022-02299-w |
Similar Items
-
Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada
by: Maria Luisa Aznar, et al.
Published: (2019-06-01) -
Comparative analysis of non-tuberculous mycobacterial lung disease and lung colonization: a case-control study
by: Shi Chen, et al.
Published: (2024-10-01) -
Clinical relevance of pulmonary non-tuberculous mycobacterial isolates in three reference centres in Belgium: a multicentre retrospective analysis
by: Yannick Vande Weygaerde, et al.
Published: (2019-12-01) -
A clinical case of non-tuberculosis mycobacterial infection of the lungs and larynx
by: О.М. Raznatovska, et al.
Published: (2024-06-01) -
Non-tuberculous mycobacterial disease: progress and advances in the development of novel candidate and repurposed drugs
by: Yuzhen Gu, et al.
Published: (2023-10-01)